SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " testing " 965 found 🔀 AI-powered Shuffle
Texas Tech University Health Sciences Center Awarded Grant to Improve Diabetes Testing Access in Rural West Texas
The American Medical Association (AMA) awarded $50,000 to Adrian Billings, M.D., Ph.D., as part of a new grant to improve access to A1C testing in West Texas.
Six months on, Iran is still standing, but survival is becoming more costly
Economic pressure is testing Iran where it is weakest and sharpening divisions within its leadership.
How A Tribal Health System Built A Wastewater Early-Warning System From Scratch
Tribal health org in remote Alaska proved wastewater surveillance can detect flu, RSV, and COVID-19 days before clinical cases in underserved communities.
San Ramon swim coach Ntatsos dives into city politics
Longtime San Ramon swim coach Paschalis Ntatsos is testing the waters of city politics this year, with the political newcomer's first-ever campaign for public office now underway as a three-way race for mayor ramps up ahead of the November election.
Jonathan Kuminga's Timberwolves Contract Exemplifies NBA's Free-Agency Problem
The risk of testing the NBA's free-agent market often outweighs the reward these days, as Jonathan Kuminga can now doubly attest.
The primaries testing Democratic 2028ers
Democrats have used their endorsements of candidates in tough primaries as a way to wield influence over the party.
Xbox to let Insiders convert physical game discs into digital entitlements later this month
Xbox will let Xbox Insiders begin testing a disc-to-digital feature from August 31, letting owners of supported physica…
Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA
Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the medication could be more potent than intended
NVIDIA DLSS 4.5 Ray Reconstruction Review
NVIDIA DLSS 4.5 Ray Reconstruction boosts image quality with a new AI-powered model that uses 20% more parameters and 35% more compute, all without sacrificing performance. Our testing shows that ray-traced visuals are enhanced, offering crisper, richer textures, especially in path tracing.
Can Integrated Mental Health Care Improve Pediatric Outcomes? A New BMC Trial Will Find Out
TEAM UP has spent nearly a decade testing what it takes to pediatric mental health care a standard. Now, a new BMC trial will take the research a step further.
Apple Seeds Seventh iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the seventh betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming one week after Apple released the sixth betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Gemini on Pixel 11 Pro testing ‘Device help’ tool
On the Pixel 11 Pro, we're seeing a new "Device help" tool for the Gemini app that provides personalized and conversational assistance...
Mozambique strengthens regulation of medicines and imported vaccines, boosting health protection
Mozambique has reached a major milestone in strengthening the regulation of medicines and imported vaccines, with its national regulatory authority recognized by the World Health Organization (WHO) as having a stable, well-functioning and integrated regulatory system.The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines under WHO’s global classification of national regulatory authorities.Mozambique becomes the 10th country in Africa to reach ML3, joining Egypt, Ethiopia, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania and Zimbabwe and marking further momentum in strengthening regulatory systems across the region.For people in Mozambique, stronger regulation means greater assurance that medicines and vaccines are appropriately evaluated for quality, safety and efficacy and monitored throughout their lifecycle. It also strengthens the country’s ability to identify and respond to safety concerns and substandard or falsified products, while supporting timely access to quality-assured health products.“Mozambique’s achievement is the result of sustained investment in regulatory capacity that will deliver crucial benefits for public health,” said Dr Sylvie Briand, WHO Chief Scientist and Assistant Director-General a.i. for Health Systems, Access and Data. “Strong regulatory systems protect people, build confidence in health products and help countries respond more effectively to evolving public health needs and challenges. Mozambique’s progress also contributes to advancing regulatory capacity across Africa and promoting more equitable access to safe and quality-assured medicines and vaccines.”Building a stronger regulatory systemMozambique’s achievement follows years of sustained efforts to build the institutions and capabilities needed for effective regulation.WHO worked closely with ANARME throughout this process, assessing the national regulatory system and supporting the authority in addressing identified gaps and strengthening priority areas.WHO evaluates national regulatory systems using its Global Benchmarking Tool (GBT), which assesses the regulatory functions required to ensure the quality, safety and efficacy of medical products. These include registration and marketing authorization, licensing, market surveillance and control, pharmacovigilance, regulatory inspection, laboratory testing and oversight of clinical trials, as applicable. WHO’s maturity levels range from 1 to 4. Reaching ML3 confirms a stable, well-functioning and integrated regulatory system, while ML4 represents an advanced system focused on continuous improvement.Benefits for Mozambique and the African continentAn ML3 regulatory system can support more timely and predictable regulatory decisions, reinforce safety monitoring and help ensure that health products entering and remaining on the market meet appropriate standards.It also creates greater opportunities for regulatory cooperation and reliance – approaches that help authorities make use of the work and decisions of trusted regulators, reduce unnecessary duplication and allocate limited resources more efficiently, while maintaining rigorous standards for quality, safety and efficacy.As the first Portuguese-speaking country in Africa to reach ML3, Mozambique’s experience can also contribute to strengthening regulatory systems and fostering greater cooperation, knowledge sharing and reliance among Portuguese-speaking countries and across the African continent. Its achievement further reinforces a more connected African regulatory ecosystem, providing a solid foundation on which the newly established African Medicines Agency can build to advance regulatory convergence and cooperation across the region.Strengthening confidence in regulatory recognitionMozambique’s achievement comes as WHO strengthens the process through which the performance of national regulatory systems is recognized.The newly established Technical Advisory Group on Regulatory Systems Strengthening (TAG-RSS) brings together independent international experts to advise WHO on whether recommendations concerning regulatory authorities reaching ML3 and ML4 and WHO-Listed Authorities, are supported by the findings of WHO evaluation processes. Its recommendations provide an additional level of independent assurance, strengthening the impartiality, transparency and credibility of WHO’s recognition process.Mozambique is among the first countries to achieve ML3 following consideration and recommendation by the TAG-RSS. As part of the same TAG-RSS process, South Africa was recommended to retain its ML3 status for the regulation of vaccines manufactured, imported or distributed in the country, following an additional WHO assessment. This extends the recognition first granted in 2022 and underscores the sustained performance of the South African Health Products Regulatory Authority (SAHPRA).The two recognitions highlight continued progress in strengthening regulatory systems across Africa, as well as the importance of continued performance, improvement and assessment in sustaining regulatory maturity.WHO will continue working with ANARME and SAHPRA to sustain these gains and support continuous improvement as science, technologies and public health needs evolve.
PS5 RPG Dawnwalker Actually Will Have 60FPS Mode, Part of Day One Patch
Rebel Wolves had it in testing
Carney warned about economic coercion. Now Trump is testing the Canadian prime minister
Canadian Prime Minister Mark Carney drew international attention earlier this year by warning that middle powers such as Canada must resist economic coercion
Why More Medical Testing Doesn’t Always Make Us Healthier
Direct-to-consumer testing will change how medicine is practiced, writes Dr. Matthew S. Davenport.
Patriots vs. Eagles Tonight: Odds, Props and Prediction
The New England Patriots and Philadelphia Eagles spent two days testing each other during joint practices.Saturday night will give the bottom half of both rosters an occasion to make an impression.It could also produce a game where points come at a premium.Philadelphia is a 2.5-point road favorite ahead of the 7 p.m. ET kickoff at […] The post Patriots vs. Eagles Tonight: Odds, Props and Prediction appeared first on HEAVY.
Fancy new business class suites cause headache for aviation industry
Airlines are competing for the fanciest business class following the boom in premium travel, but new suites require rigorous certification testing.
Hemp businesses sue Texas health agency over product testing criteria
A group of Texas hemp businesses has sued the Texas Department of State Health Services for its rules related to the testing of hemp products, which they claim are at odds with state law.
Hemp businesses sue Texas health agency over product testing criteria
A group of Texas hemp businesses has sued the Texas Department of State Health Services for its rules related to the testing of hemp products, which they claim are at odds with state law.
BioVivo Science launches VeriPalmetto with fully traceable saw palmetto supply chain
The ingredient addresses growing demand for authenticated, US-sourced saw palmetto — with direct harvester relationships, standardised fatty acid profiles and rigorous batch testing to counter adulteration risks in the category
Samsung One UI 9.5 leak hints at new premium UI design changes
Samsung is continuing to work on its upcoming One UI 9.5 update. A new testing build with the CZHD firmware has reportedly been spotted for the Galaxy S26 series. The new build gives us an early look at some of the design changes Samsung may bring with the next version of One UI. According to […]
I spent a week testing the Google Pixel 11 Pro and Pro XL, and they're harder to recommend despite some fun new Gemini features
Elegance comes at too high a cost.
Kyrgios suspended after positive cocaine test
Nick Kyrgios is provisionally suspended from tennis after testing positive for cocaine.
Baltimore’s fight with Agora tests the limits of its new consumer protection powers
Baltimore is testing its new consumer protection powers in a lawsuit against Agora, alleging it gave predatory investment advice that targeted older adults. While the city lawsuit does not name local victims, some families here have been affected.
NSF Unveils $1.5B in Science & Engineering Funding
NSF is testing more flexible grant structures for long-term and emerging research.
Mozilla Firefox 155 Enters Public Beta Testing, Here's What to Expect
Firefox 155 open-source web browser is now available for public beta testing with support for Happy Eyeballs v3 for faster page loading.
Florida holds primaries for governor and Congress, testing Trump's grip on adopted state
Florida voters cast ballots Tuesday for Republican and Democratic nominees for governor, U.S. Senate and several congressional races. The primaries will define a midterm ballot set to test President Donald Trump’s grip on his adopted state.
A Top Marathoner Needs Science to Win Big. He Comes to Wake Forest for Testing
When John Korir hit the track at Wake Forest University’s Kentner Stadium on a recent steamy summer afternoon, he needed to know one thing: Could he somehow tailor his training to boost his performance by 1%?
‘We are impatient’: meet the women protesting for change in India
From student organisers to a model-turned-activist, these women are risking their reputations – and sometimes their lives – to fight against injustice. Plus, actor Imran Khan recommends a classic film
Florida holds primaries for governor and Congress, testing Trump's grip on adopted state
Florida voters cast ballots Tuesday for Republican and Democratic nominees for governor, U.S. Senate and several congressional races
Florida holds primaries for governor and Congress, testing Trump's grip on adopted state
Florida voters cast ballots Tuesday for Republican and Democratic nominees for governor, U.S. Senate and several congressional races.
Reddit begins testing a new audio and video experience, similar to popular TikTok videos
Reddit is beginning to test video and audio versions of popular posts, allowing users to watch or listen to Reddit stories instead of just reading them.
Apple Seeds Sixth iOS 27 and iPadOS 27 Betas to Developers
Apple today seeded the sixth betas of iOS 27 and iPadOS 27 to developers for testing purposes, with the update coming one week after Apple released the fifth betas. Registered developers can download the betas from the Settings app on the iPhone or iPad by going to the General section and selecting Software Update. iOS 27 introduces Apple's smarter version of Siri, Siri AI.
Science & Medicine: San Antonio's fungus lab is on the front line of a growing drug-resistance crisis
When doctors can't identify a fungal infection, they often turn to UT Health San Antonio's Fungus Testing Laboratory, which has discovered more than 60 new species since 2013. The lab is now racing to fight drug-resistant fungi while helping bring new antifungal treatments to market.
Estée Lauder Companies (EL) Expands Color Science Research For Shade Matching
Estée Lauder Companies (NYSE: EL) announced a research collaboration with the University of Leeds and Dr. Kaida Xiao focused on advanced color science for complexion products. The partnership aims to improve shade matching accuracy in luxury foundations and related complexion lines using visual perception science. The work is expected to inform future formula development and product testing in the prestige cosmetics segment. For investors tracking how advanced data and perception science...
This bizarre star is defying physics—scientists stunned by unexplained quantum effect - Futura-Sciences
Published in Nature, the study details observations of 1E 1547.0-5408, a magnetar formed by a massive star’s supernova explosion. The star rotates once every 2.1 seconds and generates a magnetic field more than one trillion times stronger than Earth’s. Unprecedented multi-observatory campaign Testing vacuum birefringence requires magnetic fields 100 million...
Maryland’s new hospital payment model could drive up health insurance costs
Insurers warn the transition could shift more expenses to private payers and consumers while testing the stability of the state’s unique health care system.
I spent $100,000 testing my sock business idea
Allison Strumeyer says ordering 10,000 pairs of socks before launching doublesoul helped prove demand and gave her the confidence to build the company.
A top marathoner needs science to win big. He comes to Wake Forest for testing.
The fifth-fastest marathoner in the world wants to break a record this year, so her turned to Wake Forest researchers for help.
When they didn’t find fraud while testing a voting machine for the Trump admin, this cyber firm faced a wave of backlash
The Trump administration abruptly declined to renew a contract for a cybersecurity firm it hired to examine voting equipment in Puerto Rico after the company didn’t echo administration officials’ false claims of voter fraud, the firm’s executives said in their first extensive public remarks on the episode.
Pigs at Michigan county fair have swine flu. Now, people are sick, too
Although "several people" are sick and undergoing swine flu testing, the Kent County Health Department said as of Aug. 12, none have confirmed cases.
Neighbors complain about noise from Universal’s ‘Fast & Furious’ ride
Universal Studios Hollywood plans new sound barriers around its “Fast & Furious” coaster after neighbors complained about screaming during ride testing.
Report: Nate Wiggins avoided structural damage in Tuesday's injury
Ravens head coach Jesse Minter said there was optimism that cornerback Nate Wiggins avoided a serious injury after Wiggins was carted off at Tuesday's practice and further testing reportedly supported that feeling.
‘A mouse can’t tell us what works’: UK scientists to grow miniature human organs for drug testing
Organoids and tissues grown from human cells promise more accurate results, with £20m Cambridge project to create standardised models
Testing finds 85% of everyday personal care products contain unlabeled chemicals with suspected health hazards
A new study of sunscreens, baby lotions, shampoos, soaps and other everyday products found that nearly all contained chemicals not disclosed on their labels. Most contained at least one unlabeled chemical ...
Michaels reimagines in-store experience as shopping habits change
In North Texas, Michaels is testing a new way to shop and switching up some things for the customer’s in-store experience.
Google is testing Search without the 'Google Search' button (Update: Confirmed)
A new version of the Google Search homepage has been spotted, and it removes the Google Search button to make room for AI tools.
How Jefferson Health is testing new treatment for brain disorder: "It's amazing"
Spotify's New Ad-Skipping Feature Is Not Scaring Off Podcast Advertisers Yet
The platform is testing out a feature that allows paid users to skip ads on podcasts, but experts say this will likely not have any immediate impact.
iOS 27 beta 5 now available as Apple tests major Siri AI upgrade
Apple has released the fifth iOS 27 beta for developer testing. iOS 27 beta 5 continues Apple’s summer beta cycle...
Samsung starts early testing of One UI 9.5 for Galaxy S26 series
Samsung is already testing One UI 9.5 for the Galaxy S26 series. One UI 9.0, based on Android 17, officially debuted earlier this month with Samsung's new Galax
Cancel Thanksgiving? This Democratic candidate is testing limits
Opponent says the 37-year-old frontrunner for Wisconsin's Democratic governor nomination is 'not ready for prime time' ahead of the Aug. 11 primary.
New Lies of P documentary teases next game "is going to be really fun and emotionally moving"
One of the teams behind Neowiz's Souls-like Lies of P has released a short documentary detailing how they kept "testing and refining" the game.
Patriots Forced Into Major Gillette Stadium Change Before Preseason Opener
The New England Patriots are installing new turf at Gillette Stadium after the initial surface failed NFL testing before Thursday’s Colts game.
US intel assesses Putin could launch attack aimed at testing NATO unity
Recent US intelligence assessments indicate Russian President Vladimir Putin could try to test NATO’s resolve by launching a limited attack on an allied country within the next few years, according to three sources familiar with those reports.
iOS 26.6.1 likely coming soon as Apple speeds up iPhone updates
Apple appears to be testing a forthcoming iOS 26.6.1 update for iPhone users. This comes nearly two weeks after iOS...
Apple Testing iOS 26.6.1 Update for iPhones
Apple's software engineers are internally testing iOS 26.6.1, according to the MacRumors visitor logs. Apple already released macOS 26.6.1 yesterday with a fix for a security vulnerability affecting the Screen Sharing app. Apple already released macOS 26.6.1 yesterday with a fix for a security vulnerability affecting the Screen Sharing app.
The Most Basic Step of the Ebola Response Is Falling Short
Curbing the outbreak in the Democratic Republic of the Congo will require stepping up testing.
Business Restructuring Review Vol. 25 No. 4 July-August 2026
In This Issue New York Bankruptcy Court: Premature Allegations of Creditor Mistreatment Insufficient to Deny Chapter 15 Recognition of Foreign Restructuring Proceeding In In re ARD Finance, S.A., No. 25-12794 (MG), 2026 WL 817458 (Bankr. S.D.N.Y. Mar. 25, 2026), the U.S. Bankruptcy Court for the Southern District of New York was presented with a petition seeking chapter 15 recognition of Luxembourg's recently enacted bankruptcy law governing judicial reorganization proceedings. The court granted the petition, turning aside challenges to recognition voiced by a creditor group arguing that recognition should be denied based upon allegations of unfairness to creditors in the Luxembourg proceeding that would make recognition manifestly contrary to U.S. public policy. According to the bankruptcy court, recognition was warranted because: (i) the rules and procedures governing the proceeding under Luxembourg law were fundamentally fair; (ii) the petition otherwise satisfied chapter 15's recognition requirements; and (iii) the creditor group's allegations were premature, given the fact that the Luxembourg court presiding over the debtor's restructuring proceeding had not confirmed a restructuring plan, and all creditors had the right to participate fully and voice their objections in the proceeding (including the right to appeal an order approving a plan). [read more …] Florida Bankruptcy Court Examines Scope of Discovery in Chapter 15 Cases In In re Banco Master, S.A., No. 25-24568-SMG, 2026 WL 931729 (Bankr. S.D. Fla. Apr. 6, 2026), the U.S. Bankruptcy Court for the Southern District of Florida granted in part and denied in part post-recognition motions filed by an insider of a foreign debtor seeking to bar or limit discovery sought by the debtor's foreign representative concerning allegedly voidable transfers involving the debtors' U.S. real property. According to the court: (i) although chapter 15 includes its own discovery provisions among the relief that may be granted to a foreign representative, the expansive discovery available in cases under other chapters of the Bankruptcy Code is also available in chapter 15 cases; (ii) the discovery sought by the foreign representative was permissible; (iii) discovery regarding matters that were the subject of a pending adversary proceeding had to be undertaken under the more restrictive rules applicable to such proceedings; and (iv) a discovery request would be barred to the extent that it sought production of documents or testimony from a subpoenaed entity that exceeded the geographic limitations specified in such rules. [read more …] Delaware District Court Affirms Chapter 15 Recognition Order Enforcing Nonconsensual Third-Party Releases In U.S. Int'l Dev. Fin. Corp. v. Credito Real S.A.B. de C.V. SOFOM, E.N.R. (In re Credito Real S.A.B. de C.V. SOFOM, E.N.R.), 677 B.R. 192 (D. Del. 2026), appeal filed, No. 26-2356 (3d Cir. June 5, 2026), the U.S. District Court for the District of Delaware affirmed a bankruptcy court order granting chapter 15 recognition to a Mexican "concurso mercantile" proceeding and enforcing nonconsensual third-party releases approved by the Mexican court. Agreeing with the bankruptcy court that the releases were not manifestly contrary to U.S. public policy, the district court concluded: "It is well settled that U.S. bankruptcy courts can give effect to foreign orders in recognized foreign proceedings pursuant to the authority granted in Chapter 15, even when those orders contain relief unavailable under U.S. law. [The appellant's] arguments misconstrue the Supreme Court's narrow holding in Purdue, applicable in Chapter 11 cases, as well as the statutory framework of Chapter 15 and its core policy objectives. Accordingly, I will affirm the Enforcement Order." The ruling has been appealed to the U.S. Court of Appeals for the Third Circuit. [read more …] Fifth Circuit: Bankruptcy Court, Not State Court, Had Jurisdiction to Allow or Disallow Administrative Expense Claim In Storey Minerals Ltd. v. EP Energy E&P Co., LP (Matter of EP Energy E&P Co., LP), 169 F.4th 609 (5th Cir. 2026), the U.S. Court of Appeals for the Fifth Circuit affirmed lower courts' rulings disallowing a creditor's administrative expense claim. It also rejected the creditor's argument that, because the claims were predicated on state law, a state court should adjudicate the merits of the state law causes of action before the bankruptcy court could allow or disallow the claim as an administrative expense. According to the Fifth Circuit, even though the causes of action were based on state law, the bankruptcy court had jurisdiction to determine whether the creditor's claims should be conferred with administrative expense priority in the debtors' chapter 11 case. [read more …] New York Bankruptcy Court: Dismissal of Involuntary Chapter 11 Case Filed Prior to Commencement of Foreign Restructuring Proceeding Unwarranted In In re Xinyuan Real Estate Co. Ltd., No. 25-10745 (PB), 2026 WL 592250 (Bankr. S.D.N.Y. Mar. 3. 2026), the U.S. Bankruptcy Court for the Southern District of New York considered the bona fides of an involuntary chapter 11 petition filed by certain holders of U.S. dollar-denominated notes against a holding company for a group of Chinese property development companies that filed a restructuring proceeding in the Cayman Islands after the noteholders filed the involuntary chapter 11 petition. The court denied the debtor's motion to dismiss the chapter 11 case. Given the timing of the filing of the Cayman Islands restructuring proceeding, the absence of any progress in the proceeding for seven months, the debtor's need to restructure notes governed by U.S. law, and the debtor's lack of any meaningful contacts to the Cayman Islands, dismissal of the chapter 11 case was unwarranted under the applicable provision of the Bankruptcy Code, international comity, or the doctrine of forum non conveniens. [read more …] Bankruptcy Court Evaluates Trustee's Authority to Sell Avoidance Actions and Right of Target Defendants to Object In In re Law Enf't Officers Sec. Union, No. 24-70277-JAD, 2026 WL 560452 (Bankr. W.D. Pa. Feb. 27, 2026), a chapter 7 trustee sought court approval to sell certain avoidance actions to a creditor of the debtor's estate. Potential targets of the subject avoidance actions objected, arguing that such claims were nontransferable powers of the trustee rather than saleable estate property and urging the court to approve their competing settlement with the trustee. The U.S. Bankruptcy Court for the Western District of Pennsylvania disagreed with the potential defendants, holding that they lacked standing to object to the proposed sale, that avoidance actions are indeed estate property, and that the sale—rather than the settlement—best served the estate's interests. [read more …] U.S. Supreme Court Bankruptcy Roundup in Brief In Keathley v. Buddy Ayers Construction Inc., No. 25-6, 2026 WL 1686028 (U.S. June 11, 2026), the U.S. Supreme Court overturned a Fifth Circuit decision judicially estopping a chapter 13 debtor from asserting a personal injury claim against a construction company because the debtor failed to disclose the claim during his bankruptcy case. In so ruling, the Court held that "[t]he Fifth Circuit erred by artificially narrowing its inquiry to whether the debtor had knowledge of the underlying facts or a potential motive to conceal the claim." It represents the first time that the Court has applied judicial estoppel in the bankruptcy context, although it has suggested in other contexts that it may be inappropriate where an inconsistent legal position resulted from "inadvertence or mistake." Also in June, the Court denied petitions for certiorari in a few notable bankruptcy cases. [read more …] Newsworthy Heather Lennox (Cleveland/New York) (Star Individual), Bruce Bennett (Los Angeles) (Senior Statesperson), Kevyn D. Orr (Washington) (Eminent Practitioner), Gregory M. Gordon (Dallas) (Band 1), Carl E. Black (Cleveland), Corinne Ball (New York) (Senior Statesperson), Brad B. Erens (Chicago), Jeffrey B. Ellman (Atlanta), T. Daniel Reynolds (Cleveland), and Dan T. Moss (Washington/New York) were recognized as leading lawyers in the practice area Bankruptcy/Restructuring in the 2026 edition of Chambers USA: The World's Leading Lawyers for Business. The 2026 edition of Lawdragon 500 Leading Bankruptcy and Restructuring Lawyers ranked the following lawyers: Corinne Ball (New York) (Hall of Fame), Bruce Bennett (Los Angeles), Carl E. Black (Cleveland), Jeffrey B. Ellman (Atlanta), Brad B. Erens (Chicago), Gregory M. Gordon (Dallas), Heather Lennox (Cleveland/New York), Joshua M. Mester (Los Angeles), and Kevyn D. Orr (Washington). Fabienne Beuzit (Paris) and Jasper Berkenbosch (Amsterdam) were among the "Leading Individuals" ranked in the 2026 edition of The Legal 500 EMEA guide in the field of Restructuring and Insolvency or Insolvency. Rodolphe Carrière (Paris) was named a "Next Generation Partner" in the practice area Insolvency. Sid Pepels (Amsterdam) was selected by Global Restructuring Review's 40 under 40 2026. He was identified as a Rising Star within the global cross-border restructuring community. Global Restructuring Review is a leading digital subscription service, news outlet, and information platform dedicated exclusively to cross-border insolvency and corporate restructuring law. Fabienne Beuzit (Paris), Rodolphe Carrière (Paris), and Isabelle Maury (Paris) were recognized in the 2027 edition of The Best Lawyers in France™ in the practice area Insolvency and Reorganization Law. An article written by Corinne Ball (New York) titled "Comity and Fairness are Critical to Granting Additional Assistance under Chapter 15: A Canadian Reverse Vesting Order and Related Releases in Proceedings Involving Canadian and U.S.-Affiliated Companies Are Approved" was published in the June 24, 2026, edition of the New York Law Journal. An article written by Caitlin K. Cahow (Detroit) titled "New York Bankruptcy Court Weighs In on Adequate Assurance of Future Performance under Assigned Leases and Chapter 11 Plan Exculpation Provisions" was published on June 8, 2026, in Lexis Practical Guidance. An article written by Trisha L. Mowbray (Real Estate; Chicago) and Ryan Sims (Washington) titled "Chapter 11 Plan that Abridged Non-Debtor Lessee's Rights to Remain in Possession After Rejection Unconfirmable as Having Been Proposed in Bad Faith" was published on June 16, 2026, in the Harvard Law School Bankruptcy Roundtable. An article written by Dan T. Moss (Washington/New York), Corinne Ball (New York), Isel M. Perez (Miami), and David S. Torborg (Washington) titled "Texas Bankruptcy Court Adopts Barnet Rule Requiring Foreign Debtor to Have U.S. Assets to Be Eligible for Chapter 15 Relief" was published on June 10, 2026, in Lexis Practical Guidance. An article written by Daniel J. Merrett (Atlanta) and Nathaniel Parr (Atlanta) titled "Southern District of Texas Clarifies Post-Purdue Course for Consensual Third-Party Releases and Gatekeeping Provisions" was published on June 11, 2026, in Lexis Practical Guidance. An article written by Corinne Ball (New York) titled "LMEs, Sophisticated Investors and Equitable Mootness: The Fifth and Third Circuits Warn Against Testing the Limits of Chapter 11" was published in the June 2026 issue of the American Bankruptcy Institute Journal. Nicholas J. Morin (New York) was quoted in an article titled "Serta Ruling Offers Damages Road Map in Lender-on-Lender Disputes," published by Bloomberg Law on July 7, 2026. The article discussed U.S. Bankruptcy Judge Christopher Lopez's July 7, 2026, ruling that participating lenders in Serta Simmons Bedding's 2020 non-pro rata uptier exchange breached the credit agreement's ratable-sharing provision, and awarding excluded lenders more than $261 million in damages. The opinion resolves six years of litigation related to Serta's 2020 transaction, where it raised $200 million in new financing and exchanged $1.2 billion of term loans for $875 million in superpriority debt. Judge Lopez found that the debt-for-debt exchange constituted a "payment" under the credit agreement, requiring proportional sharing among lenders, and dismissed various defenses raised by the participating lenders. The case is Serta Simmons Bedding LLC v. AG Centre Street Partnership (In re Serta Simmons Bedding LLC), 2026 WL 1968535 (Bankr. S.D. Tex. Jul. 7, 2026). The New York Law Journal has recognized Andrew M. Butler (New York) as a 2026 "Rising Star" in Restructuring/Bankruptcy as part of the New York Legal Awards. The Rising Star category recognizes New York's most promising lawyers age 40 and under who have distinguished themselves through exceptional legal work, leadership, and contributions to the profession. Lawyer Spotlight: Daniel J. Merrett Dan Merrett, a partner in the Atlanta Office, has spent nearly 20 years representing all manner of stakeholders in complex corporate restructurings and chapter 11 reorganizations. His practice extends to related transactions and disputes involving acquisitions; divestitures; credit facilities; securities; environmental obligations; and vendor, employee, and governance matters. Dan has substantial experience managing mass tort liabilities, including the restructurings and related chapter 11 cases of affiliates of Georgia Pacific and Johnson & Johnson, implemented to resolve asbestos and talc liabilities. He also represents key parties in energy and infrastructure matters, including facility owners, EPC contractors, and joint-venture parties. Dan was a key player in the restructuring teams in the historic bankruptcies of the City of Detroit and Chrysler. His other significant representations in chapter 11 cases include AFA Foods, Alpha Natural Resources, Dana Corporation, M&G Chemicals, McDermott International, Monster/CareerBuilder, Transtar Industries, and Westinghouse. He is licensed in both the United States and England & Wales and recognized in restructuring by Chambers USA and Best Lawyers.
Google Messages rolling out long-press menu redesign with precise copying
After testing started in January, Google Messages is expanding beta access to a redesign of the long-press menu that aids one-handed usage.
Coco Gauff believes in fairness in sports — but not attacks on the trans community
Gauff weighed in on the new genetic testing policy implemented by the Women’s Tennis Association last month.
Google Chrome slowly starts rolling out updated navigation bar with Gemini button on Android [Gallery]
Google Chrome is testing a pretty major new redesign on mobile devices – Android and iPhone – which has dual...
"Know Your Status" During August HIV Awareness Events
The Coastal Health District prevention team is offering two free community health events this August to coincide with Southern HIV/AIDS Awareness Day and National Faith HIV/AIDS Awareness Day.
Coco Gauff appears to support WTA efforts to protect sport's fairness, laments 'attack' on trans community
Coco Gauff voiced support for the WTA's SRY gene-testing policy while expressing concern about animosity directed at the transgender community.
Dozens of health workers at epicenter of Congo’s Ebola outbreak protest lack of payment
Dozens of health workers working at the epicenter of Congo’s Ebola outbreak are protesting Thursday to demand payment for their wages.
Dozens of health workers at epicenter of Congo’s Ebola outbreak protest lack of payment
Dozens of health workers working at the epicenter of Congo’s Ebola outbreak are protesting Thursday to demand payment for their wages.
Health workers at epicenter of Congo’s Ebola outbreak protest lack of payment
Health workers at the epicenter of Congo’s Ebola outbreak are protesting over unpaid wages
Dozens of health workers at epicenter of Congo’s Ebola outbreak protest lack of payment
Health workers at the epicenter of Congo’s Ebola outbreak are protesting over unpaid wages.
Dozens of health workers at epicenter of Congo’s Ebola outbreak protest lack of payment
Dozens of health workers working at the epicenter of Congo’s Ebola outbreak are protesting Thursday to demand payment for their wages.
Coco Gauff says she supports trans community and fairness in women’s sports amid new WTA policy
Gauff was asked about a new eligibility policy in professional women's tennis, which is based on a one-off gene test.
Viewpoint: Europe needs a new scientific contract
The White House's new science strategy should be required reading in the Berlaymont and every European capital.Not because Europe should copy it. Parts of it should concern Europeans deeply. But because it asks the question Europe has so far avoided while steadily losing ground in the global race for technological leadership.Europe already possesses many of the world's finest universities, scientists and research-intensive companies. It produces world-leading research in fields ranging from quantum technologies and biotechnology to climate science. Yet time and again Europe generates the scientific breakthroughs while others build the companies, industries and strategic advantages around them, particularly in digital technologies. Increasingly, we find ourselves regulating technologies whose underlying capabilities were developed elsewhere.This is not primarily a scientific failure. It is an institutional one.The settlement that shaped modern science policy emerged after the Second World War. In Science, the Endless Frontier, Vannevar Bush argued that governments should invest in fundamental research while protecting scientists from political direction. Public investment was justified precisely because no government, university or company could predict where the next transformative discovery would emerge.That scientific contract served liberal democracies extraordinarily well. It underpinned decades of advances in medicine, computing, energy and communications, but the world for which it was designed no longer exists.Artificial intelligence is transforming not only technology but the production of knowledge itself. Advanced chips, computing power, data and scientific instruments have become strategic assets. Scientific knowledge now diffuses globally almost instantly. Competitive advantage increasingly lies not in making discoveries first, but in possessing the infrastructure, capital, engineering capability and institutions required to translate those ideas into products, industries and strategic advantage.The old boundaries between science, industrial policy, national security and geopolitics have largely disappeared. Dual-use technologies now underpin both economic power and military deterrence.The US has recognised this shift. In July, the White House published Science: A New Golden Age, a comprehensive attempt to rethink the relationship between science and national power. The report builds on Bush's legacy, but departs from his framework in important ways. Science is no longer treated simply as the source of future discoveries. It is presented as the foundation of economic resilience, technological leadership and national security. AI, advanced infrastructure and the capacity to build become as important as discovery itself.Yet the report also reveals a striking paradox. The same administration calling for “a new golden age” of US science has simultaneously proposed deep cuts to the federal research enterprise while expanding political influence over the allocation of public research funding. Europe should therefore distinguish between the report's diagnosis and its prescription. The diagnosis, that science has become a strategic asset, is compelling. But the prescription is self-defeating. Long-term technological leadership depends on strong universities, academic freedom and the institutional autonomy that makes scientific discovery possible. This distinction matters. Bush's achievement was never simply to make science serve national strength. It was to establish a division of labour in which governments invested in research without attempting to direct discovery itself. Scientific breakthroughs emerge precisely because researchers retain the freedom to pursue questions whose value cannot yet be demonstrated and whose conclusions cannot be anticipated.Neither China, nor the USAs science becomes more strategically important, the temptation to politicise it inevitably grows. But scientific freedom is not an obstacle to technological leadership, it is an essential precondition.China represents the opposite model. For decades it has integrated science, manufacturing, infrastructure and industrial policy into a single national strategy. Its ability to mobilise resources around critical technologies is formidable. But it does so within an authoritarian system where scientific priorities are increasingly inseparable from political power.Europe should imitate neither model. It should learn from the strategic ambition of the US without importing its growing politicisation of science. And it should learn from China's capacity to build without adopting its concentration of power.Instead, Europe needs a scientific contract of its own. Bush's scientific contract protected the freedom to discover because the defining challenge of the 20th century was producing new knowledge. Europe's next scientific contract must preserve that freedom while ensuring that scientific discoveries can be converted into technological, industrial and strategic capability. Because in a transactional world, Europe's freedom to shape its own future depends on its capacity to build it.Related articlesThe US ‘golden age’ science strategy: what Europeans need to knowEuropean researchers sound the alarm that Trump rule changes will hit cooperationNIH turmoil risks reciprocal EU-US access to health research fundingThis does not mean subordinating free science to competitiveness or industrial policy. On the contrary. Scientific autonomy remains the first principle of Europe's next scientific contract. Governments should not direct scientific discovery. Their responsibility is to ensure that Europe's scientific, industrial, financial and regulatory institutions work together rather than in isolation.Meeting that responsibility requires far more than research funding. European researchers need access to world-class computing infrastructure, advanced laboratories, shared datasets and scientific facilities. Innovative companies need patient capital, testing environments and a genuine single market in which they can scale without facing 27 different regulatory regimes. Public procurement must evolve from purchasing existing technologies to creating markets for new ones. Regulators must become partners in experimentation rather than guardians of yesterday's rules.A connecting architectureEurope does not need to invent the Defense Advanced Research Projects Agency (Darpa) model from scratch. Britain's Aria, Germany's Sprind and Wellcome Leap already show that Europe can build institutions capable of taking high-risk, mission-oriented bets while preserving democratic accountability. The challenge now is not to create more isolated initiatives, but to connect them to Europe's broader scientific, industrial and financial system so that breakthrough discoveries can scale.Above all, Europe must stop treating research, innovation, industrial policy, finance and security as separate policy domains. The challenge is no longer to create excellent institutions in each of these fields, but to make them work as one European innovation system. Europe's strength will increasingly depend not on excellence within institutions, but on excellence across them.Europe's ambition should be neither to imitate the US nor to emulate China. It should demonstrate that scientific freedom, democratic legitimacy and technological capability are not competing objectives, but mutually reinforcing strengths. In an age of geopolitical rivalry, Europe's greatest advantage may ultimately be its ability to attract the world's best talent by combining scientific freedom, democratic openness and technological ambition.Bush's scientific contract helped define the 20th century because it protected the freedom to discover. Europe's challenge is not to abandon that achievement but to extend it. The defining task of Europe's next scientific contract is to preserve the freedom to discover while building Europe's capacity to translate scientific discovery into technological power.Kaare Nielsen is founder of Pomus, a Danish think tank on science and innovation.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Abdul El-Sayed's victory sends tremors through Democratic Party
His win in Michigan sets up a high-stakes contest in November, testing a left-wing candidate's popularity in a swing state.
ECU Health Medical Center begins using rapid blood culture testing tool
ECU Health Medical Center has announced that they are the fifth institution in the nation to begin using the BioMerieux Vitek Reveal analyzer, a rapid blood cul
Testing Astronaut Health in 30 Seconds of Weightlessness
UC Davis researcher Rich Whittle joined an international team aboard a parabolic flight to study how microgravity affects blood flow to protect astronauts during long-duration space missions.
Cardiovascular imaging contrast agent recalled due to risk of contamination
The recall was announced after testing revealed the presence of potentially harmful particulate matter. Customers were urged to return any unused vials immediately.
UT San Antonio scientist highlights growing threat of antifungal resistance
For decades, scientists have studied antibiotic resistance, which is how bacteria evolve mechanisms to evade lifesaving drugs. Now, researchers are warning that a similar challenge is emerging among fungi, where resistance to frontline antifungal medications is making serious infections increasingly difficult to treat. Nathan Wiederhold, PharmD, director of the Fungus Testing Laboratory and professor […]
Wisconsin governor’s race tests limits of Democrats’ leftward shift
After years of Republican rule, Wisconsin Democrats are testing whether a democratic socialist is a viable candidate for governor in a swing state.
UT San Antonio scientist highlights growing threat of antifungal resistance
For decades, scientists have studied antibiotic resistance, which is how bacteria evolve mechanisms to evade lifesaving drugs. Now, researchers are warning that a similar challenge is emerging among fungi, where resistance to frontline antifungal medications is making serious infections increasingly difficult to treat. Nathan Wiederhold, PharmD, director of the Fungus Testing Laboratory and professor […]
Galaxy S27 Ultra is already cooking, and I know what software Samsung is testing it with right now
Galaxy S27 Ultra news has been making headlines in the past couple of weeks, and the latest leak details one key component — the software.
Three-Team Mock Trade: Nets Trade Porter Jr., Land Duren
A complex proposal sends Brooklyn’s leading scorer to Houston while bringing an All-Star center to the Nets, testing Sean Marks’ commitment to his current roster rebuild.
Linux 7.2-rc6 Released: "This RC Is Huge"
Like clockwork, the Linux 7.2-rc6 kernel is now available for testing in working toward the stable Linux 7.2 kernel in hopefully two week's time.
High Schoolers become summer scientists at USD
A group of local high school students have ditched the lazy summer days and instead are testing hypotheses and conducting their own scientific research inside the University of San Diego’s labs.
Jaguars Experimenting with Anton Harrison at LT
Jacksonville shuffles the trenches while dealing with an injury, testing Anton Harrison’s versatility on Trevor Lawrence’s blind side while trying Walker Little at right tackle.
Here’s when One UI 9.0 Beta 5 update could release
Official One UI 9.0 will begin rolling out next week, but Samsung plans to release the Galaxy S26 Beta 5 update as well. Internal testing is reportedly underway, and users are expected to welcome the next Beta this August. On July 22, Samsung showcased One UI 9 full experience at the Unpacked event. It comes […]
Editorial: Pennsylvania health insurance rates need triage
The cost of staying healthy is climbing. The cost of getting sick is even worse. Prescription drug costs are up. So is the amount of money people spend in urgent care — and that’s affordable compared with an emergency room visit. Testing, diagnostics, office visits, the little extras you don’t
Reddit is testing a new way to watch — and listen to — its viral posts
Reddit is developing a new video experience that lets users watch — or simply listen to — its most popular posts, taking inspiration from the viral TikTok videos that pair Reddit stories with gameplay or other footage. CEO Steve Huffman said the feature is already in the works and could begin testing later this year.
WhatsApp is testing a new folder for messages from large businesses
WhatsApp will automatically move messages from large businesses to a new folder a few hours after you receive them
They Worked To Protect Public Health. Now They Want the Public’s Votes.
They’re known for touting pandemic precautions, Affordable Care Act plans, and testing for lead in schools. This year, some former public health officials are touting themselves — for governor or senator.
Anthropic says its AI models also broke out and hacked other companies
AI company Anthropic says that during routine testing, some of its models accessed the internet and hacked into three separate organization’s systems – and that it didn’t notice the models had done so until an internal review prompted by rival OpenAI disclosing its models did the same.
They Worked To Protect Public Health. Now They Want the Public’s Votes.
By Phil Galewitz, Christine Mai-Duc, and Amanda Seitz | KFF Health News A handful of former public health officials are campaigning for top statewide offices across the country, testing whether their experience with covid and other hot-button health issues will appeal to voters in November. The ...
U.S. turns to war weary Ukraine for help with drone technology
Ukraine’s ambassador to the U.S. told NBC News that the two nations signed an agreement last week so Ukrainian combat drones can be sent to the U.S. for military testing and evaluation.
First look: Gemini could soon help you set up your new Android phone
Google is testing a Gemini AI setup assistant to streamline onboarding for new Android devices. Check it out in action!
DJI Osmo Pocket 4P Lab Test: Rolling Shutter, Dynamic Range and Exposure Latitude
DJI Osmo Pocket 4P Lab Test by CineD, testing rolling shutter, dynamic range and exposure latitude in D-Log and D-Log2.
The new "science golden age" looks suspiciously like a grift
This edition of PN is made possible by paid subscribers. Become one ⬇️ 🚀 Subscribe to PN 🚀 The Trump regime is trying to usher in a “Golden Age in Science” where scientific research is run like a Trump family business, artificial intelligence is all that matters, profit is everything, and expertise is for chumps. Or at least that’s the vision emerging from a new 123-page “Report to the President” from Michael Kratsios, the Director of the White House Office of Science and Technology Policy. In a normal administration, you could probably skip over learning about a science policy document — but this is no normal administration, and this is no normal science policy document. Instead, it’s Trump’s attempt to end the actual golden age of science that was kicked off in 1945 with the publication of '“The Endless Frontier” by Vannevar Bush. [ ](https://www.publicnotice.co/p/harmeet-dhillon-portland) [ Harmeet Dhillon demonstrates danger of posting through it ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Liz Dye · Jul 29 [ Read full story ](https://www.publicnotice.co/p/harmeet-dhillon-portland) Bush, at President Franklin Delano Roosevelt’s request, laid out a vision of federal support for science that centered on funding universities to do basic research, saying that as long as those institutions were “vigorous and healthy and their scientists are free to pursue the truth wherever it may lead, there will be a flow of new scientific knowledge to those who can apply it to practical problems in Government, in industry, or elsewhere.” Kratsios’s report is supposed to be the successor to Bush’s, and even apes the format, but this isn’t really a document about science policy. It’s one about ending science research as we know it in favor of shoveling cash at big tech companies. While it might be temping to wave this away as an aspirational policy document, Trump has already begun to shift billions in research funds to AI projects and has taken a hatchet to science funding across the board. He’s teed up the shift Kratsios proposes here, and since neither Congress nor the Supreme Court seem inclined to stop him from doing whatever he wants with taxpayer money, it isn’t doomering or hyperbole to say we are staring down the barrel of a world where the only “science” the government intends to support is for-profit tech and defense advancements. Science for dummies Part of how you can tell this isn’t a document about science is that you are immediately faced with an absolute wall of business-speak of the worst sort. Did you know we must “tightly couple our science and technology enterprises to ensure that groundbreaking ideas invented in the United States are rapidly prototyped, tested, manufactured, and scaled domestically”? You do now! That tone isn’t surprising, because Kratsios has no background in science or research. He has a bachelor’s in political science and spent most of his career working for Peter Thiel at Thiel Capital. After a stint in the first Trump administration as Chief Technology Officer, where he also did not do any science, Kratsios was tasked in 2020 with overseeing the Pentagon’s research budget for a brief time, a position that, as the Wall Street Journal put it, “carries a great deal of power in terms of dictating investment allocations.” He spent the Biden years at Scale AI as “head of strategy,” which you will also note is neither a science nor a research job. But Scale AI has contracts with the Department of Defense and, as the Washington Post wrote in 2023, “has been aggressively pitching itself as the company that will help the US military in its existential battle with China.” And now you have the necessary background for our new golden age, which is going to be a golden age of taking money away from scientists and universities and giving it to companies like Scale AI. A note from Aaron: Working with brilliant contributors like Lisa takes resources. If you aren’t already a paid subscriber, please become one to support our work. 👇 Subscribe In a genuinely galling move, Katsios spends a lot of time slamming universities because of “administrative burdens on researchers” and the “well-documented inefficiencies” in academia, the message being that those damn universities waste the time of amazing researchers with paperwork. Except it’s the administration that is attempting to impose inefficient, unnecessary burdens on those researchers with a proposed Office of Management and Budget rule that would require senior political appointees to approve every science grant and ensure it aligns with Trump’s personal priorities. Researchers would also have to seek prior government approval to attend conferences or publicize their research. And political appointees could terminate any grant at any time if they feel like it. [ ](https://www.publicnotice.co/p/omb-rule-science-funding) [ The murder of expertise ](https://www.publicnotice.co/p/omb-rule-science-funding) Lisa Needham · Jun 11 [ Read full story ](https://www.publicnotice.co/p/omb-rule-science-funding) But when it comes to AI, we’re going to “restore permissionless innovation.” The report proposes to give lucky ducky innovators a pile of cash up front for grants lasting five years or longer, saying “awards should be fully-funded in year one, with all resources earmarked upfront, to minimize administrative burdens and reduce pressure for researchers to generate intermediate results to secure continued funding.” Yeah, wouldn’t want to have to make the Very Special Tech Bros show results or get money parceled out year by year like the plebes at universities. The report also proposes that we should have “fast grants” with “simplified applications requiring just a few pages of writing” because that is definitely how science works, just writing a bit off the dome and getting some cash. [ ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) [ Tech elites are turning AI into ChatGPTrump ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Paul Waldman · July 29, 2025 [ Read full story ](https://www.publicnotice.co/p/trump-ai-action-plan-altman-llms) Oh, and we should have prizes and challenges, where multiple teams compete. The proposed prizes include incentives like “advance procurement commitments,” which means the federal government agrees to buy whatever is being developed. There’s also “regulatory fast-tracking,” making sure all those great AI thingies don’t have to wait too long to be unleashed on a market. These aren’t incentives to do science. These are incentives to develop things with tax dollars that you can then sell to the government for more tax dollars. In the suggestion that might be the most unhinged, the most very opposite of how both government and research work, our new age will include “golden tickets.” That’s where an individual reviewer in an agency — yes, just one person — can “recommend unconventional proposals that may not pass consensus-driven review panels” because somehow this will “surface valuable ideas too divisive for committees and attract higher quality reviewers by empowering them to exercise independent scientific judgment.” Yes, that’s saying that a random person in an agency should be able to shovel money at some idea even if it can’t pass a review panel, and that the opportunity to do so will attract better employees because apparently all the best minds in science are chomping at the bit to be allowed to unilaterally fund AI research based on their personal vibes. But that isn’t at all how actual science works, and actual scientists aren’t unhappy about review panels. They work collaboratively, not siloed in some secret race to create the next AI chatbot. A 2020 study by the National Bureau of Economic Research examined whether peer review panels succeed in helping agencies predict which research ideas will best advance science. Peer review was better at finding “diamond in the rough” applicants than a single government program official. How about that. Trump always wants a taste It’s painfully clear that what Katsios is trying to do here is turn the whole of government science research and funding into the sort of “move fast and break things” paradigm that is the hallmark of big tech. That method works to line the pockets of tech executives, but it isn’t science. There’s a reason the government funds different kinds of research than private tech companies do. What Katsios either fails to understand or deliberately ignores is that the federal government is the main funder of basic research precisely because it can take a long time for it to bear fruit and is not intended to be profitable as such. “Basic” here does not mean rudimentary or simple, but rather research that is designed to advance scientific knowledge instead of achieving a specific outcome or product. Big tech companies don’t widely fund that sort of research, because it doesn’t make them money. Industry dollars account for only about 20 percent of basic research funding, while the government contributes around 60 percent. Big tech companies and startups do, however, rely on and benefit from that basic research. A 2019 study found that 35 percent of all patents obtained by venture-backed startups from 1976 to 2016 cited federally supported research. Basic research funded by the NIH contributed to every single drug the FDA approved from 2010 to 2016. [ ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) [ The Saudi nuclear farce and governance by whim and meme ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Noah Berlatsky · Jul 27 [ Read full story ](https://www.publicnotice.co/p/trump-saudi-nuclear-deal) Unlike inventing the next ChatGPT, actual science is slow and iterative. Government funding of research that, on its face, would not appear to lead to any big new invention is actually what underpins those big new inventions. If the government hadn’t funded research into desert lizard venom, we wouldn’t know about semaglutide, and we wouldn’t have Ozempic. If research scientists hadn’t studied how bees optimize nectar foraging within a colony, we wouldn’t have the algorithm that assigns internet traffic across computer servers. The report assiduously ignores that a symbiotic, profitable relationship between the federal government, universities, and private companies already exists. Each federal research dollar generates about $1.50 to $3.00 in long-term economic benefits. The $36 billion the government awarded in NIH research funding in fiscal year 2025 generated $94 billion in new economic activity. Trump’s proposed new golden age is intended to strip those billions from universities, resulting in the dismantling of departments and the shuttering of labs. But Katsios has a plan for that: Universities should just become trade schools to churn out no-show STEM degrees! “Require universities and community colleges to embed practical technical training and externships into STEM curricula. Let hands-on experience and industry credentials count toward degrees.” It’s quite the feat to, on the one hand, strip schools of funding for scientific research while simultaneously demanding to control what is taught and, oh, also, colleges need to give degrees to employees at big tech companies just for being employees at big tech companies. The new golden age would also exacerbate the brain drain Trump’s policies have already caused. Nature found that in the first quarter of 2025, US scientists submitted 32 percent more job applications abroad than in 2024. A March 2025 poll by Nature of roughly 1,600 scientists found that over 1,200 said they were considering leaving the country. Europe is investing $565 million to make it a “magnet for researchers” and provide funding for scientists who relocate. The new golden age is also about embedding Trump’s xenophobia into the fabric of American science. The report complains of an “over-reliance on foreign students” that “creates a security challenge our institutions are ill-equipped to address” and that a “reliance on foreign talent sidelines American students.” This is, to put it mildly, nonsense. International students pay far higher tuition and often receive no financial aid. Their tuition dollars are what make it possible for American students to get financial aid. In the 2023-2024 school year alone, international students contributed $43.8 billion to the US economy and supported over 378,000 jobs. Those 1.1 million international students accounted for only six percent of the total number of students in higher education that year, but were such an economic engine that for every three international students, one job was created or supported. It’s impossible not to wonder whether part of Trump’s loathing for universities and their leading role in scientific research is that there is no way for him to corrupt the process and make money off it in the same way he can by giving millions and billions to Silicon Valley types who, in turn, give him millions in cash. There’s no way for his children to invest in universities that the government then gives no-bid contracts to, fattening the family’s bottom line, which is pretty much the Trump sons’ current venture capital practice. Trump and Katsios’s view of science is narrow, cramped, and wrong. We’re not in a crisis, we’re not a failed state. We’ve been a science superpower for decades, and the only thing that threatens that is Donald Trump. Tech bros are already living high off the hog in this administration. They don’t need any more of our tax dollars. Hopefully this new golden age never comes to pass. Thanks for reading Public Notice. This post is public so feel free to share it. Share We’ll be back with more tomorrow. If you appreciate today’s PN, please do your part to keep us free by signing up for a paid subscription. 🚀 Subscribe to PN 🚀 Thanks for reading, and for your support.
NSF testing new Ph.D. model giving trainees academic and industry experience
Young life scientists have been increasingly abandoning academia, a seismic shift that has fueled calls for rethinking graduate education. On Wednesday,
Earn Some Crazy Money Early by Testing the New Crazy Taxi on PS5
Closed beta coming in September
National Science Foundation to help build AI-enabled labs
Carolina is part of a program that will use artificial intelligence to speed the testing of research ideas across the country.
Mental health help for those affected by Seattle Center mass shooting
In the aftermath of the mass shooting at Seattle Center, people may be feeling a range of emotions that are testing their mental health and sense of safety.